Vitamin D and breast cancer risk.
Best Pract Res Clin Endocrinol Metab. 2008 Aug;22(4):587-99.
Vitamin D and breast cancer risk.
Colston KW.
Division of Cellular and Molecular Medicine, St George’s University of London, Cranmer Terrace, London SW17 0RE, UK. kcolston@sghms.ac.uk
In addition to its important role in the maintenance of the skeleton, there is mounting evidence that vitamin D has effects on other body systems, and that adequate supplies of vitamin D are likely to be required for optimal health. Vitamin D is obtained both from dietary sources and from cutaneous synthesis with exposure to sunlight. Some epidemiological studies have indicated that vitamin D deficiency and decreased exposure to solar UVB radiation increase the risk of some cancers, including breast cancer. The active metabolite of vitamin D, 1,25-dihydroxy-vitamin D(3), is synthesized primarily in the kidney, and has been shown in laboratory studies to have potent anti-proliferative effects on breast cancer cells. Normal and neoplastic breast tissues contain the vitamin D receptor, and gene ablation studies have implicated the receptor in normal breast development. Several polymorphisms have been identified in the vitamin D receptor gene, and these have been associated with risk of breast cancer in some studies. Local synthesis of 1,25-dihydroxyvitamin D(3) in breast tissue may contribute to maintenance of normal cell function, which could be impaired in vitamin D deficiency.
« Dietary calcium, vitamin D, and the risk of colorectal cancer. | Home | Vitamin D, respiratory infections, and asthma. »
Comments
Trackbacks
Leave a Comment
You must be logged in to post a comment.